A carregar...
Development of chidamide for peripheral T-cell lymphoma, the first orphan drug approved in China
Peripheral T-cell lymphoma (PTCL) is a set of rare and highly heterogeneous group of mature T- and NK-cell neoplasms associated with poor outcomes and lack of standard and effective therapies. The total number of newly diagnosed cases of PTCL yearly in China is estimated about 50,000. Chidamide (CS0...
Na minha lista:
| Publicado no: | Intractable Rare Dis Res |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
International Research and Cooperation Association for Bio & Socio-Sciences Advancement
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4995415/ https://ncbi.nlm.nih.gov/pubmed/27672541 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5582/irdr.2016.01024 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|